Non-steroidal MRAs: A new treatment pillar for chronic kidney disease in type 2 diabetes
1 Apr 2023
13:00
14:00
MR 109 ABFE
Organized by Bayer
Organized by
| Time | Session |
|---|
|
13:00
13:10
|
Welcome and introductions
Masaomi Nangaku
|
|
13:10
13:25
|
MRAs in 2023: still all the same?
Angela Wang
|
|
13:45
13:55
|
Slowing CKD progression and reducing CV events with Finerenone – From FIDELIO-DKD to FIDELITY
Roberto Pecoits-Filho
|
|
13:55
14:00
|
Close
Masaomi Nangaku
|